What is Kura Oncology Inc (KURA) stock price today?

Kura Oncology Inc (KURA) currently trades at $8.83 per share. The stock has a market capitalization of $776.67M and a P/E ratio of —x.

Is KURA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Kura Oncology Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Kura Oncology Inc's revenue and earnings?

Kura Oncology Inc has trailing twelve-month (TTM) revenue of $67.48M with profit margins of 0.00%. Earnings per share (EPS) is $-3.18.

KURA

Kura Oncology Inc

NASDAQ: KURA · HEALTHCARE · BIOTECHNOLOGY

$8.83

+0.91% today

Updated 2026-04-30

Market cap

$776.67M

P/E ratio

—

P/S ratio

11.51x

EPS (TTM)

$-3.18

Dividend yield

—

52W range

$5 – $12

Volume

1.5M

Market cap

$776.67M

P/E ratio

—

P/S ratio

11.51x

EPS (TTM)

$-3.18

Dividend yield

—

52W range

$5 – $12

Volume

1.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$31.17

+253.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $114.95M — positive

Risks

- Thin margins at 0.00%

- Revenue declining -67.80% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$53.88M	$67.48M	$67.48M
Net income	$-135.84M	$-152.63M	$-173.98M	$-278.67M	$-81.00M
EPS	—	—	—	—	$-3.18
Free cash flow	$-110.69M	$-124.99M	$133.84M	$-70.70M	$114.95M
Profit margin	—	—	-322.89%	-412.95%	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-23	WILSON, TROY EDWARD	Buy	6,103	—
2026-03-23	WILSON, TROY EDWARD	Buy	6,103	$6.15
2026-03-18	MALLEY, THOMAS	Buy	10,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
KURA	$776.67M	23	3.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Kura Oncology Inc trades at $8.83. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $67.48M.

Frequently asked questions

What is Kura Oncology Inc's stock price?

Kura Oncology Inc (KURA) trades at $8.83.

Is Kura Oncology Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Kura Oncology Inc (KURA)?

The analyst target price is $31.17, representing +253.0% upside from the current price of $8.83.

What is Kura Oncology Inc's revenue?

TTM revenue is $67.48M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio11.51x

ROE-94.80%

Beta0.24

50D MA$8.72

200D MA$8.89

Shares out0.09B

Float0.06B

Short ratio—

Avg volume1.5M

Performance

1 week-5.61%

1 month+7.63%

3 months+6.45%

YTD-15.78%

1 year—

3 years—

5 years—

Compare

KURA vs LLY →KURA vs JNJ →KURA vs ABBV →Stock screener →